DIVIDEND ANNOUNCEMENT: Oramed Pharmaceuticals Inc (NASDAQ:ORMP) on 01/08/2026 declared a dividend of $0.2500 per share

Oramed Pharmaceuticals Inc (NASDAQ:ORMP) on 01/08/2026 declared a dividend of $ 0.2500 per share payable on January 26, 2026 to shareholders of record as of January 16, 2026. Dividend amount recorded is an increase of $ 0.25 from last dividend Paid.

Oramed Pharmaceuticals Inc (NASDAQ:ORMP) has paid dividends since 1970, has a current dividend yield of 7.6452598572% and has increased its dividends for 0 successive years.

Oramed Pharmaceuticals Inc's market cap is $ 130,152,540 and has a PE ratio of 0.00. The stock price closed yesterday at $ 3.27 and has a 52 week low/high of $ 1.82 and $ 3.30.

Oramed Pharmaceuticals Inc. is a pharmaceutical company engaged in the research and development of pharmaceutical solutions with a technology platform. Co. has developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its Protein Oral Delivery (POD) technology is designed to protect drug integrity and increase absorption. Its pipeline includes ORMD-0801 (Oral Insulin) Diabetes, ORMD-0801 (Oral Insulin) NASH, and ORMD 0901 (Oral GLP-1).

For more information on Oramed Pharmaceuticals Inc click here.